Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma

Pediatric Blood and Cancer

Volumn 51, Issue 2, 2008, Pages 275-279

  Jain, Neelam ^a,d   Krull, Kevin R ^a,b,d   Brouwers, Pim ^a,b,e   Chintagumpala, Murali M ^a,b   Woo, Shiao Y ^c  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

CNS tumors; Late effects of treatment; Neuropsychology; Radiation oncology

Indexed keywords

ANTINEOPLASTIC AGENT; TOPOTECAN;

ARTICLE; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COGNITION; COMPARATIVE STUDY; FEMALE; HEARING LOSS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LONG TERM CARE; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PRIORITY JOURNAL; SKULL IRRADIATION; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT OUTCOME; ADOLESCENT; CEREBELLUM TUMOR; PERCEPTION DEAFNESS; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; RADIATION EXPOSURE;

ADOLESCENT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COGNITION; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MEDULLOBLASTOMA; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 45549095134     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21580     Document Type: Article

References (42)

1. Blaney SM, Kun LE, Hunter J. Tumors of the central nervous system. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 5th edition. New York: NY: Lippincott Williams & Wilkins; 2006. pp 786-864.
2. Dennis M, Spiegler BJ, Hetherington CR, et al. Neuropsychological sequelae of the treatment of children with medulloblastoma. J Neurooncol 1996;29:91-101.
3. Palmer SL, Goloubeva O, Reddick WE, et al. Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. J Clin Oncol 2001;19:2302-2308.
4. Mostow EN, Byrne J, Connelly RR, et al. Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol 1991;9:592-599.
5. Lannering B, Marky I, Lundberg A, et al. Long-term sequelae after pediatric brain tumors: Their effect on disability and quality of life. Med Pediatr Oncol 1990;18:304-310.
6. Kramer JH, Crowe AB, Larson DA, et al. Neuropsychological sequelae of medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1997;38:21-26.
7. Grau C, Overgaard J. Postirradiation sensorineural hearing loss: A common but ignored late radiation complication. Int J Radiat Oncol Biol Phys 1996;36:515-517.
8. Grau C, Moller K, Overgaard M, et al. Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991;21:723-728.
9. Anteunis LJ, Wanders SL, Hendriks JJ, et al. A prospective longitudinal study on radiation-induced hearing loss. Am J Surg 1994;168:408-411.
10. Kwong DL, Wei WI, Sham JS, et al. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys 1996;36:281-289.
11. Low WK, Fong KW. Long-term hearing status after radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx 1998;25:21-24.
12. Sataloff RT, Rosen DC. Effects of cranial irradiation on hearing acuity: A review of the literature. Am J Otol 1994;15:772-780.
13. Bohne BA, Marks JE, Glasgow GP. Delayed effects of ionizing radiation on the ear. Laryngoscope 1985;95:818-828.
14. Schell MJ, McHaney VA, Green AA, et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 1989;7:754-760.
15. McHaney VA, Thibadoux G, Hayes FA, et al. Hearing loss in children receiving cisplatin chemotherapy. J Pediatr 1983;102:314-317.
16. Weatherly RA, Owens JJ, Catlin FI, et al. cis-platinum ototoxicity in children. Laryngoscope 1991;101:917-924.
17. Browett PJ, Cooke HM, Seeker-Walker LM, et al. Chromosome 22 breakpoints in variant Philadelphia translocations and Philadelphia-negative chronic myeloid leukemia. Cancer Genet Cytogenet 1989;37:169-177.
18. Kortmann RD, Kuhl J, Timmermann B, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 2000;46:269-279.
19. Miettinen S, Laurikainen E, Johansson R, et al. Radiotherapy enhanced ototoxicity of cisplatin in children. Acta Otolaryngol Suppl 1997;529:90-94.
20. Kirkbride P, Plowman PN. Platinum chemotherapy, radiotherapy and the inner ear: Implications for "standard" radiation portals. Br J Radiol 1989;62:457-462.
21. Teh BS, Woo SY, Butler EB. Intensity modulated radiation therapy (IMRT): A new promising technology in radiation oncology. Oncologist 1999;4:433-442.
22. Huang E, Teh BS, Strother DR, et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 2002;52:599-605.
23. Soomal R, Saran F, Brada M, In regard to Huang to et al.: Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 2003;55: 853; author reply 853-854.
24. Wechsler D. Wechsler adult intelligence scale - Third edition. New York: Psychological Corporation; 1997.
25. Wechsler D. Wechsler Intelligence Scale for Children - Third Edition. San Antonio, TX: Psychological Corporation; 1991.
26. Elliott CD. Differential Ability Scales. San Antonio, TX: Psychological Corporation; 1990.
27. Roid GH, Miller LJ. Leiter international performance scale-Revised. Lutz, FL.: Psychological Assessment Resources, Inc.; 1997.
28. Brouwers P, Heyes MP, Moss HA, et al. Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: Relationships to clinical status and therapeutic response. J Infect Dis 1993;168:1380-1386.
29. Beery KE. The Beery-Buktenica Developmental Test of Visual-Motor Integration: Administration, scoring, and teaching manual. Parsippany, NJ: Modern Curriculum Press; 1997.
30. Tiffin J. The Purdue pegboard. Purdue, IN: Purdue University; 1948.
31. Trites RL. Neuropsychological Test Manual. Ottawa, Ontario, Canada: Royal Ottawa Hospital; 1977.
32. Cohen J. Statistical power analysis for the behavioral science. Hillsdale, NJ: Erlbaum; 1988.
33. Jankovic M, Brouwers P, Valsecchi MG, et al. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet 1994;344:224-227.
34. Mulhern RK, Palmer SL, Merchant TE, et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005;23:5511-5519.
35. Kieffer-Renaux V, Bulteau C, Grill J, et al. Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation doses. Dev Med Child Neurol 2000;42:741-745.
36. Silber JH, Radcliffe J, Peckham V, et al. Whole-brain irradiation and decline in intelligence: The influence of dose and age on IQ score. J Clin Oncol 1992;10:1390-1396.
37. Buono LA, Morris MK, Morris RD, et al. Evidence for the syndrome of nonverbal learning disabilities in children with brain tumors. Child Neuropsychol 1998;4:144-157.
38. Nathan PC, Maze R, Spiegler B, et al. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation. Pediatr Blood Cancer 2004;42:24-29.
39. Mabbott DJ, Spiegler BJ, Greenberg ML, et al. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol 2005;23:2256-2263.
40. Ris MD, Packer R, Goldwein J, et al. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A Children's Cancer Group study. J Clin Oncol 2001;19:3470-3476.
41. Monje ML, Mizumatsu S, Fike JR, et al. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002;8:955-962.
42. Taylor HG, Alden J. Age-related differences in outcomes following childhood brain insults: An introduction and overview. J Int Neuropsychol Soc 1997;3:555-567.